Dongfang Hospital Affiliated to Tongji University
11
4
5
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
18%
2 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
PDO Based Drug Sensitive Test in R/M SGC
Role: collaborator
PDO Based Drug Sensitive Test in R/M HNSCC
Role: collaborator
An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)
Role: collaborator
Rituximab and RASi in Patients with IgAN
Role: collaborator
Pronase in Improving Endoscopic Mucosal Clarity During Colonoscopy for Patients with Colitis
Role: collaborator
A Real-world Study to Evaluate the Effectiveness of Intravascular Lithotripsy in Moderate to Severe Calcification Lesion of Lower Extremity Femoropopliteal Artery
Role: collaborator
A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy
Role: collaborator
Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer
Role: collaborator
Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic Hyperplasia
Role: collaborator
Nutritional Management in Respiratory Critically Ill Patients -an Observational Study in Mainland China
Role: collaborator
Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure Technology
Role: collaborator
All 11 trials loaded